{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:34:01Z","timestamp":1775028841836,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.drudis.2020.04.011","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T12:14:47Z","timestamp":1587384887000},"page":"1142-1145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["ET-traps offer a potential therapeutic tool for use in different autoimmune diseases"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7338-9553","authenticated-orcid":false,"given":"Arjun","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin H.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2020.04.011_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00060.2009","article-title":"Regulation of blood pressure and salt homeostasis by endothelin","volume":"91","author":"Kohan","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.drudis.2020.04.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/147616","article-title":"Endothelin receptors expressed by immune cells are involved in modulation of inflammation and in fibrosis: relevance to the pathogenesis of systemic sclerosis","volume":"2015","author":"Elisa","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.drudis.2020.04.011_bib0015","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/heart.89.10.1221","article-title":"Acute endothelin A receptor antagonism improves pulmonary and systemic haemodynamics in patients with pulmonary arterial hypertension that is primary or autoimmune and related to congenital heart disease","volume":"89","author":"Apostolopoulou","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.drudis.2020.04.011_bib0020","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/art.10895","article-title":"Endothelin and endothelin receptor antagonists in systemic rheumatic disease","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.drudis.2020.04.011_bib0025","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.drudis.2019.07.008","article-title":"Endothelin-1 traps as a potential therapeutic tool: from diabetes to beyond?","volume":"24","author":"Jain","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2020.04.011_bib0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10989-017-9653-x","article-title":"Creating a soluble binder to Endothelin-1 based on the natural ligand binding domains of the endothelin-1 (G-protein-coupled) receptor","volume":"25","author":"Jain","year":"2017","journal-title":"Int. J. Peptide Res. Ther."},{"key":"10.1016\/j.drudis.2020.04.011_bib0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/er.2007-0015","article-title":"The role for endoplasmic reticulum stress in diabetes mellitus","volume":"29","author":"Eizirik","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.drudis.2020.04.011_bib0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000046319","article-title":"Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins","volume":"90","author":"Chen","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.drudis.2020.04.011_bib0045","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1006\/jmcc.2000.1197","article-title":"Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors","volume":"32","author":"Chen","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0050","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1152\/ajpendo.00540.2002","article-title":"Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications","volume":"284","author":"Chen","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2020.04.011_bib0055","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2337\/diabetes.49.4.662","article-title":"Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats","volume":"49","author":"Evans","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2020.04.011_bib0060","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/ajh\/hpw078","article-title":"Endothelin-1 overexpression exaggerates diabetes-induced endothelial dysfunction by altering oxidative stress","volume":"29","author":"Idris-Khodja","year":"2016","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.drudis.2020.04.011_bib0065","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0895-7061(02)03060-1","article-title":"Elevated plasma endothelin-1 levels in diabetes mellitus","volume":"15","author":"Schneider","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.drudis.2020.04.011_bib0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40200-019-00400-7","article-title":"In vivo studies demonstrate that endothelin-1 traps are a potential therapy for type I diabetes","volume":"18","author":"Jain","year":"2019","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.drudis.2020.04.011_bib0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40200-018-0360-8","article-title":"Endothelin-1 traps potently reduce pathologic markers back to basal levels in an in vitro model of diabetes","volume":"17","author":"Arjun","year":"2018","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.drudis.2020.04.011_bib0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/cells7100161","article-title":"Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development","volume":"7","author":"Yap","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2020.04.011_bib0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res."},{"key":"10.1016\/j.drudis.2020.04.011_bib0090","first-page":"CR616","article-title":"Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis","volume":"8","author":"Pache","year":"2002","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.drudis.2020.04.011_bib0095","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.joca.2014.11.002","article-title":"The emerging role of endothelin-1 in the pathogenesis of subchondral bone disturbance and osteoarthritis","volume":"23","author":"Sin","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.drudis.2020.04.011_bib0100","first-page":"51","article-title":"Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis","volume":"30","author":"Haq","year":"1999","journal-title":"J. Med."},{"key":"10.1016\/j.drudis.2020.04.011_bib0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainres.2009.01.070","article-title":"Endothelial endothelin-1 over-expression using receptor tyrosine kinase tie-1 promoter leads to more severe vascular permeability and blood brain barrier breakdown after transient middle cerebral artery occlusion","volume":"1266","author":"Leung","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.drudis.2020.04.011_bib0110","first-page":"522","article-title":"Downregulation of intercellular adhesion molecule-1 expression on human synovial fibroblasts by endothelin-1","volume":"26","author":"Iwabuchi","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/03009749609069994","article-title":"Endothelin-1 modulates the expression of adhesion molecules on fibroblast-like synovial cells (FLS)","volume":"25","author":"Schwarting","year":"1996","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0120","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1189\/jlb.1207827","article-title":"Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1","volume":"84","author":"Conte","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10067-005-0007-2","article-title":"A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis","volume":"25","author":"Kuryliszyn-Moskal","year":"2006","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1006\/cyto.1998.0347","article-title":"Endothelin 1 receptors, signal transduction and effects on DNA and proteoglycan synthesis in rat articular chondrocytes","volume":"10","author":"Khatib","year":"1998","journal-title":"Cytokine"},{"key":"10.1016\/j.drudis.2020.04.011_bib0135","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/cyto.2001.1001","article-title":"Mechanism of inhibition of endothelin-1-stimulated proteoglycan and collagen synthesis in rat articular chondrocytes","volume":"17","author":"Khatib","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.drudis.2020.04.011_bib0140","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1523\/JNEUROSCI.21-14-05358.2001","article-title":"Local injection of endothelin-1 produces pain-like behavior and excitation of nociceptors in rats","volume":"21","author":"Gokin","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2020.04.011_bib0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/jpet.113.205567","article-title":"Endothelin-1-induced endoplasmic reticulum stress in disease","volume":"346","author":"Jain","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2020.04.011_bib0150","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1073\/pnas.1222560110","article-title":"Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1","volume":"110","author":"D\u2019haeseleer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2020.04.011_bib0155","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbrc.2014.07.119","article-title":"Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor","volume":"451","author":"Lin","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl. 1)","key":"10.1016\/j.drudis.2020.04.011_bib0160","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2377-9-S1-S3","article-title":"Characteristics of compounds that cross the blood\u2013brain barrier","volume":"9","author":"Banks","year":"2009","journal-title":"BMC Neurol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3329\/jhpn.v31i1.14749","article-title":"White blood cell count in women: relation to inflammatory biomarkers, haematological profiles, visceral adiposity, and other cardiovascular risk factors","volume":"31","author":"Farhangi","year":"2013","journal-title":"J. Health Popul. Nutr."},{"key":"10.1016\/j.drudis.2020.04.011_bib0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0008-6363(02)00657-0","article-title":"Endothelin-1 induced proinflammatory markers in the myocardium and leukocytes of guinea-pigs: role of glycoprotein IIB\/IIIA receptors","volume":"57","author":"Molero","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.drudis.2020.04.011_bib0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fimmu.2012.00118","article-title":"Oral inflammatory diseases and systemic inflammation: role of the macrophage","volume":"3","author":"Hasturk","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0180","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0021-5155(97)00032-4","article-title":"Endothelin-1 and intraocular inflammation in pigmented rabbit eyes","volume":"41","author":"Shoji","year":"1997","journal-title":"Jpn J. Ophthalmol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0185","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/354645","article-title":"Endothelin-1 role in human eye: a review","volume":"2010","author":"Salvatore","year":"2010","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0190","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11892-016-0815-6","article-title":"Presence and risk factors for glaucoma in patients with diabetes","volume":"16","author":"Song","year":"2016","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.drudis.2020.04.011_bib0195","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/bmj.332.7546.890","article-title":"Systemic lupus erythematosus","volume":"332","author":"D\u2019Cruz","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.drudis.2020.04.011_bib0200","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/ard.50.7.526-c","article-title":"Raised plasma concentrations of endothelin-1 in systemic lupus erythematosus","volume":"50","author":"Julkunen","year":"1991","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.drudis.2020.04.011_bib0205","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/art.39212","article-title":"Anti-endothelin receptor type A autoantibodies in systemic lupus erythematosus-associated pulmonary arterial hypertension","volume":"67","author":"Guo","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0961203307076509","article-title":"Bosentan use in systemic lupus erythematosus patients with pulmonary arterial hypertension","volume":"16","author":"Mok","year":"2007","journal-title":"Lupus"},{"issue":"Suppl. 2","key":"10.1016\/j.drudis.2020.04.011_bib0215","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/ar2193","article-title":"Vasculitis: mechanisms involved and clinical manifestations","volume":"9","author":"Guillevin","year":"2007","journal-title":"Arthritis Res. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.drudis.2020.04.011_bib0220","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar2186","article-title":"How does endothelial cell injury start? The role of endothelin in systemic sclerosis","volume":"9","author":"Abraham","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.drudis.2020.04.011_bib0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2431-8-33","article-title":"Endothelin 1 levels in relation to clinical presentation and outcome of Henoch Schonlein purpura","volume":"8","author":"Fessatou","year":"2008","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.drudis.2020.04.011_bib0230","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1001\/jama.1990.03450220030012","article-title":"Endothelin-1 and vasculitis","volume":"264","author":"Kanno","year":"1990","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1016\/j.drudis.2020.04.011_bib0235","first-page":"iii39","article-title":"Endothelin in human autoimmune diseases with renal involvement","volume":"45","author":"Neuhofer","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.drudis.2020.04.011_bib0240","article-title":"miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.04.011_bib0245","first-page":"379","article-title":"Clinical and immunological characteristics of autoimmune Addison disease: a nationwide Swedish multicenter study","volume":"102","author":"Dalin","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2020.04.011_bib0250","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1530\/eje.0.1350696","article-title":"High plasma levels of endothelin-1 in untreated Addison\u2019s disease","volume":"135","author":"Letizia","year":"1996","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0255","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1530\/EJE-16-0581","article-title":"Management of endocrine disease: regenerative therapies in autoimmune Addison\u2019s disease","volume":"176","author":"Gan","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0260","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/403808","article-title":"Pain in amyotrophic lateral sclerosis: a neglected aspect of disease","volume":"2011","author":"Handy","year":"2011","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.drudis.2020.04.011_bib0265","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.nbd.2014.01.002","article-title":"Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death","volume":"65","author":"Ranno","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.drudis.2020.04.011_bib0270","first-page":"S1","article-title":"HIV\/AIDS and chronic kidney disease","author":"Naicker","year":"2019","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0275","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/QAD.0000000000001092","article-title":"Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons","volume":"30","author":"Fitzpatrick","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.drudis.2020.04.011_bib0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146355","article-title":"Endothelin-1 predicts hemodynamically assessed pulmonary arterial hypertension in HIV infection","volume":"11","author":"Parikh","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.04.011_bib0285","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1681\/ASN.2012080857","article-title":"Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?","volume":"24","author":"Tourret","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.drudis.2020.04.011_bib0290","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/HYPERTENSIONAHA.119.12105","article-title":"Endothelin: 30 years from discovery to therapy","volume":"74","author":"Barton","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.drudis.2020.04.011_bib0295","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.drudis.2019.10.007","article-title":"Trapping endothelin-1 to hunt down cardiovascular disease?","volume":"24","author":"Wernly","year":"2019","journal-title":"Drug Discov. Today"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620301598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620301598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:45:07Z","timestamp":1761223507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644620301598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1359644620301598"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2020.04.011","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ET-traps offer a potential therapeutic tool for use in different autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2020.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}